Skip to main content

Table 2 Univariate regression analyses of predictors on failure of sulfonylurea treatment in patients with type 2 diabetes.

From: TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes

  Odds ratio (95% CI) P-value
Gender 0.98 (0.56-1.74) 0.95
Age (yr) 1.00 (0.97-1.03) 0.98
Diabetes duration (<5 yrs vs. >5 yrs) 1.65 (0.86-3.17) 0.13
Sulfonylurea daily dose (mg) 1.01 (0.97-1.06) 0.57
TCF7L2 genotype (rs7903146; per allele effect) 1.57 (1.01-2.45) 0.046
TCF7L2 genotype (CC vs. TT) 2.09 (1.02-4.27) 0.043